Latest filing published 08 Oct 2020 for Immunome Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
I. Wistar Morris III: trading record in brief
I. Wistar Morris III discloses dealings in 2 companies, chiefly Cempra, Inc. and Immunome Inc. We count 11 filings; the first trade dates from 8 February 2012 and the latest from 6 October 2020.
On the market, this insider has only ever bought: 8 purchases, €320k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 option exercise.
A typical purchase (the median) is worth €40k.
Most recently, on 8 October 2020, the filings show a transaction in Immunome Inc. The last purchase on record was published on 10 February 2012, which is 5,386 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to I. Wistar Morris III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 882,475 sharesCommon StockSEC:0001209191-20-054317:0
- 38,464 sharesCommon StockSEC:0001209191-20-054317:1
- 2,500 shares@ US$7.62Common StockSEC:0001209191-12-042731:0
- 16,667 shares@ US$6.00Common StockSEC:0001209191-12-008923:0Canonical exit: 8 May 2012 (T+90)
- 1,025 shares@ US$6.00Common StockSEC:0001209191-12-008923:1Canonical exit: 8 May 2012 (T+90)
- 16,666 shares@ US$6.00Common StockSEC:0001209191-12-008923:2Canonical exit: 8 May 2012 (T+90)
6 of 6 declarations
